Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21422081 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Atomoxetine;   Drug: Placebo;   Behavioral: Parent Training

Indicates status has not been verified in more than two years